- Executive summary
- 1. Introduction
- 2. Mandate and project outline
- 3. Conceptual clarifications
- a. About Treatment, Harm Reduction and Prevention
- b. About Best Practice, Quality Standards and Guidelines
- c. A quality concept for drug demand reduction
- 4. Methodology
- a. National and international project partners
- b. Methodology used for drug treatment and harm reduction
- c. Methodology used for prevention standards
- 5. Consensus building process in the EU
- a. Expert seminars
- b. Stakeholder surveys
- c. European conference of stakeholders
- d. Stakeholder comments on the proposed standards
- 6. Proposed Lists of Minimum Quality Standards
- a. Prevention standards
- b. Treatment/rehabilitation standards
- c. Harm reduction standards
- 7. Implementation of standards at national level
- a. Data on acceptability of proposed standards
- b. Data on expected implementation problems
- c. Lessons from models of implementation
- 8. Ideas for further research and follow-up projects
- a. Missing Information: a gap analysis
- b. Proposals for an extended consensus building process
- c. Moving from proposed lists to international implementation guidelines
- d. Monitoring and evaluating the implementation process
- 9. References, tables, technical terms, abbreviations
- 10. Annexes to the report
- 10.1 List of experts involved as project partners
- 10.2 List of steering group members
- 10.3 First interim report
- 10.4 Instructions for document search and transmission
- 10.5 List of templates treatment/rehabilitation and harm reduction
- 10.6 Inventory of quality standards
- 10.7 Correspondence of EQUS prevention standards and European drug prevention quality standards
- 10.8 Minutes of first expert seminar
- 10.9 Minutes of second expert seminar
- 10.10 Second interim report
- 10.11 List of conference partparticipants
- 10.12 Conference working paper
- 10.13 Conference report
- 10.14 Questionnaire for on-line stakeholder survey
Persistent link: https://www.econbiz.de/10010528007